Viewing Study NCT07482995


Ignite Creation Date: 2026-03-26 @ 3:14 PM
Ignite Modification Date: 2026-03-31 @ 5:49 AM
Study NCT ID: NCT07482995
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-03-19
First Post: 2026-02-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Effects of Baduanjin Exercise on Improving Health in Sedentary Young and Middle-Aged Adults
Sponsor: China-Japan Friendship Hospital
Organization:

Study Overview

Official Title: A Multicenter, Randomized Controlled Trial to Evaluate the Efficacy and Mechanisms of Baduanjin on Improving Health Outcomes in Sedentary Young and Middle-Aged Adults
Status: NOT_YET_RECRUITING
Status Verified Date: 2026-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The goal of this clinical trial is to learn if a 12-week Baduanjin exercise program can improve health in sedentary young and middle-aged adults. The main questions it aims to answer are:

1. Does the Baduanjin program improve participants' cardiorespiratory fitness (measured as peak oxygen uptake)?
2. Does it improve their body composition, muscle strength, balance, and flexibility?
3. Does it reduce their daily sitting time?

Researchers will compare the Baduanjin training group to a health education control group to see if Baduanjin is more effective in improving these health outcomes.

Participants will:

1. Be randomly assigned to one of the two groups.
2. If in the Baduanjin group, attend supervised group sessions and practice at home for 12 weeks.
3. Complete a series of assessments at the beginning, middle, and end of the study, including fitness tests, body measurements, and questionnaires.
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: